Tryptamine Therapeutics ( (AU:TYP) ) has provided an announcement.
Tryptamine Therapeutics Ltd has announced a change in the substantial holding of its shares by Dr. William James Garner. The change, effective March 31, 2025, shows an increase in the number of fully paid ordinary shares held by Dr. Garner from 198,926,720 to 205,631,200, although his voting power decreased from 17.47% to 14.29%. This adjustment was due to a private placement involving 7,500,000 shares valued at $150,000. The shift in voting power reflects changes in the company’s share distribution, potentially impacting shareholder dynamics and governance.
More about Tryptamine Therapeutics
YTD Price Performance: -17.50%
Average Trading Volume: 1,669,632
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$51.8M
See more insights into TYP stock on TipRanks’ Stock Analysis page.